Get notified of page updates
Using ctDNA Blood Test to Screen for Cancer DNA after Treatment for Early-Stage TNBC and/or an Inherited or Tumor BRCA Mutation; Followed by Study Comparing Niraparib with Placebo for People with Cancer DNA found in their Blood (ZEST)
Early-stage TNBC or early-stage breast cancer with a BRCA mutation
Clinicaltrials.gov identifier:NCT04915755
Glossary on
off
About the Study
The ZEST study has two parts, a screening portion that will look for evidence of cancer cell in the bloodstream, and an intervention portion that is open to people who test positive for cancer cell in their bloodstream.
Note: This study is no longer enrolling.
This Study is Open To:
NOTE: This study is closed.
This Study is NOT Open To:
NOTE: This study is closed.
Early-stage TNBC or early-stage breast cancer with a BRCA mutation
Clinicaltrials.gov identifier:NCT04915755